Symbolbild · KI-generiert
Eikon Therapeutics, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Eikon Therapeutics, Inc. | EIKN | NASDAQ | 499 Mio. USD |
| REGENXBIO Inc. | RGNX | NASDAQ | 501 Mio. USD |
| Ginkgo Bioworks Holdings, Inc. | DNA | NYSE | 503 Mio. USD |
| Silence Therapeutics Plc American Depository Share | SLN | NASDAQ | 491 Mio. USD |
| ARS Pharmaceuticals, Inc. | SPRY | NASDAQ | 509 Mio. USD |
| Verastem, Inc. | VSTM | NASDAQ | 510 Mio. USD |
| Cybin Inc. | HELP | NASDAQ | 485 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.